Cardica Inc (CRDC)

[nlightn]

not that it means or interprets into anything other than what is stated,..

but this is a little piece of info i found interesting,..granted i'm attempting to connect some dots that might be non-existent.

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

so if J&J is a potential buyer of ISRG and IRSRG has placed $2MM into CRDC for further development of their Xchange surgical cutter that becomes a very interesting development.

then there is also other big boys that are seeking out investments in this sector specifically,..GOOG being one of those and also GE,...

so,...CRDC will have a game changer product with their 5m cutter,...it has and will get continued attention as developments are positive.

like i mentioned there might not be any factual and/or real dots to connect,..but it's fun speculating ;^)

the story ==>

~~~~~~~~~~~~~~~~~~~~~~~~~~~~

3 Health Care Stocks to Own in a Dangerous Market

2. Intuitive Surgical Inc. (ISRG - Get Report)

With robotic-assisted surgery gaining ground, medical appliances and equipment firm Intuitive Surgical has immense growth potential.

Intuitive manufactures da Vinci Surgical Systems and related instruments and accessories which are used in robotic-assisted surgery.

ISRG could also be a potential takeover candidate for Johnson & Johnson, which is on the prowl for acquisitions in the surgical robot space.

While the company cooled off slightly with its three-year average revenue growth down below 7% and net income dropping below the industry average, it is showing promising signs of growth in 2015. Annual revenues for 2015 grew to $2.38 billion, up nearly 12% and net income surged over 40% to $588 million.

Analysts expect the company to grow earnings by over 14% annually in the next five years, pacing ahead at a rate much faster than the 9.03% recorded in the previous half a decade.

With over $3.3 billion in cash (nearly 20% of share value), zero debt and profit margins of nearly 25%, Intuitive Surgical checks the boxes of being a performer suitable for long-term investors. The fact that the ISRG stock trades at a 5-year expected PEG ratio of 1.81 vis-a-vis larger medical device firms like Medtronic at 2.47 and Stryker Corp at 1.86 makes it even more attractive.